CUI JINGRONG JEAN (Chief Scientific Officer) sold 9.2% of their position (55.50K shares) of TURNING POINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.56M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−1.90K
Price / share
$61.76
Trade value
$117.34K
% of position
Common Stock
Shares
−3.60K
Price / share
$62.70
Trade value
$225.72K
% of position
Common Stock
Shares
−3.69K
Price / share
$63.88
Trade value
$235.59K
% of position
Common Stock
Shares
−4.01K
Price / share
$64.67
Trade value
$259.46K
% of position
Common Stock
Shares
−600.00
Price / share
$65.81
Trade value
$39.49K
% of position
Common Stock
Shares
−1.80K
Price / share
$67.52
Trade value
$121.54K
% of position
Common Stock
Shares
−2.07K
Price / share
$68.62
Trade value
$142.18K
% of position
Common Stock
Shares
−828.00
Price / share
$69.54
Trade value
$57.58K
% of position
Common Stock
Shares
−3.60K
Price / share
$63.04
Trade value
$227.07K
% of position
Common Stock
Shares
−8.93K
Price / share
$64.04
Trade value
$571.69K
% of position
Common Stock
Shares
−4.67K
Price / share
$65.03
Trade value
$303.76K
% of position
Common Stock
Shares
−1.30K
Price / share
$65.66
Trade value
$85.36K
% of position
Common Stock
Shares
−1.87K
Price / share
$62.50
Trade value
$117K
% of position
Common Stock
Shares
−10.67K
Price / share
$63.36
Trade value
$675.86K
% of position
Common Stock
Shares
−5.96K
Price / share
$63.92
Trade value
$381.03K
% of position
Net shares
−55.50K
Net value
-$3.56M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/4/2020 | S · Sale | −1.90K | $61.76 | $117.34K | 0.3% | 605.38K | 603.48K |
| Common Stock Indirect | 6/4/2020 | S · Sale | −3.60K | $62.70 | $225.72K | 0.6% | 603.48K | 599.88K |
| Common Stock Indirect | 6/4/2020 | S · Sale | −3.69K | $63.88 | $235.59K | 0.6% | 599.88K | 596.20K |
| Common Stock Indirect | 6/4/2020 | S · Sale | −4.01K | $64.67 | $259.46K | 0.7% | 596.20K | 592.18K |
| Common Stock Indirect | 6/4/2020 | S · Sale | −600.00 | $65.81 | $39.49K | 0.1% | 592.18K | 591.58K |
| Common Stock Indirect | 6/4/2020 | S · Sale | −1.80K | $67.52 | $121.54K | 0.3% | 591.58K | 589.78K |
| Common Stock Indirect | 6/4/2020 | S · Sale | −2.07K | $68.62 | $142.18K | 0.4% | 589.78K | 587.71K |
| Common Stock Indirect | 6/4/2020 | S · Sale | −828.00 | $69.54 | $57.58K | 0.1% | 587.71K | 586.88K |
| Common Stock Indirect | 6/5/2020 | S · Sale | −3.60K | $63.04 | $227.07K | 0.6% | 586.88K | 583.28K |
| Common Stock Indirect | 6/5/2020 | S · Sale | −8.93K | $64.04 | $571.69K | 1.5% | 583.28K | 574.35K |
| Common Stock Indirect | 6/5/2020 | S · Sale | −4.67K | $65.03 | $303.76K | 0.8% | 574.35K | 569.68K |
| Common Stock Indirect | 6/5/2020 | S · Sale | −1.30K | $65.66 | $85.36K | 0.2% | 569.68K | 568.38K |
| Common Stock Indirect | 6/8/2020 | S · Sale | −1.87K | $62.50 | $117K | 0.3% | 568.38K | 566.51K |
| Common Stock Indirect | 6/8/2020 | S · Sale | −10.67K | $63.36 | $675.86K | 1.9% | 566.51K | 555.84K |
| Common Stock Indirect | 6/8/2020 | S · Sale | −5.96K | $63.92 | $381.03K | 1.1% | 555.84K | 549.88K |
| Total | −55.50K | -$3.56M | ||||||
Common Stock
IndirectCommon Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 300K | Indirect |
| Common Stock | 1M | Direct |
| Total | 1.30M | 1M direct·300K indirect |